The International Society on Thrombosis and Haemostasis (ISTH) just selected the Palais des Congrès de Montréal and Montréal as their host venue for their 2023 ISTH Annual Congress. Thanks to the efforts of the two partners, combined with the support of key resources from the life sciences community, nearly 8,000 delegates will converge to Montréal in five years’ time.
The bid was widely supported by the scientific community. Dr. Susan Kahn and Dr. Marc Rodger, co- directors of CanVECTOR, the Canadian Venous Thromboembolism Clinical Trials and Outcomes Research Network, put together a conference program focused on the development of young and emerging researchers, which wowed the leadership of the international association, which currently has 4,000+ members from 94 countries.
Over 600 pharma and healthcare organizations operate in Greater Montréal, making it Canada’s biggest laboratory. Ranked 7th among North America’s Top 20 cities for life sciences and health technology employment concentration,1it is home to 600 establishments and institutions, including 150 public and university research centres . The bid for the 2023 ISTH Annual Congress was endorsed by the Société des sciences vasculaires du Québec, Thrombosis Canada and the Canadian Hematology Society, among others.